Fabrazyme 35mg/1 vial

Description

Fabrazyme 35mg/1 vial

Active substance
Agalsidase beta (Agalsidase beta)
Indications
Fabry’s disease.

Contraindications for use
High risk of development of severe reactions of hypersensitivity to agalsidase beta.

Side effect
The most serious reactions are allergic and anaphylactic reactions.

General reactions: ≥ 5% – chills, fever, heat or cold, hot flushes, pain in the extremities, chest pain, lumpy feeling, peripheral swelling, back pain, pallor, face swelling, myalgia, muscle spasms .

Infections: upper respiratory tract infections, lower respiratory tract infections, sinusitis, pharyngitis, fungal infections, viral infections, local infections.

On the part of the respiratory system: ≥ 5% – shortness of breath, nasal congestion, congestion in the respiratory system.

On the part of the digestive system: ≥ 5% – nausea, vomiting, abdominal pain, diarrhea, toothache, dry mouth.

From the central nervous system and peripheral nervous system: ≥ 5% – headache, paresthesia, weakness, dizziness, drowsiness, burning sensation.

From the cardiovascular system: ≥ 5% – arterial hypertension, tachycardia, arterial hypotension, bradycardia, thinning of the ventricular wall.

Dermatological reactions: ≥ 5% – itching, hives, rash.

From the sense organs: noise in the ears, hypoacusia.

Other: increased incidence of injuries.

Active substance
Agalsidase beta (Agalsidase beta)
Indications
Fabry’s disease.

Contraindications for use
High risk of development of severe reactions of hypersensitivity to agalsidase beta.

Side effect
The most serious reactions are allergic and anaphylactic reactions.

General reactions: ≥ 5% – chills, fever, heat or cold, hot flushes, pain in the extremities, chest pain, lumpy feeling, peripheral swelling, back pain, pallor, face swelling, myalgia, muscle spasms .

Infections: upper respiratory tract infections, lower respiratory tract infections, sinusitis, pharyngitis, fungal infections, viral infections, local infections.

On the part of the respiratory system: ≥ 5% – shortness of breath, nasal congestion, congestion in the respiratory system.

On the part of the digestive system: ≥ 5% – nausea, vomiting, abdominal pain, diarrhea, toothache, dry mouth.

From the central nervous system and peripheral nervous system: ≥ 5% – headache, paresthesia, weakness, dizziness, drowsiness, burning sensation.

From the cardiovascular system: ≥ 5% – arterial hypertension, tachycardia, arterial hypotension, bradycardia, thinning of the ventricular wall.

Dermatological reactions: ≥ 5% – itching, hives, rash.

From the sense organs: noise in the ears, hypoacusia.

Other: increased incidence of injuries.